Table 5.
Comparison of distributions of the secondary continuous outcomes between the two intervention groups in each analysis set (intention-to-treat or per protocol)
| Outcome | Population | Intervention group | Percentiles | N | Mean (SD) | (Minimum, maximum) | P of difference | ||
|---|---|---|---|---|---|---|---|---|---|
| 25% | 50% | 75% | |||||||
| NIHSS score Range of possible scores at 91+/-14 days (RS): 0 to 42 Worst = 42 | Intention-to-treat (ITT) | Group 0 | |||||||
| Group 1 | |||||||||
| Per protocol (PP) | Group 0 | ||||||||
| Group 1 | |||||||||
| EQ-5D-5 L score at 91+/-14 days RS: 0 to 100 Worst = 0 | ITT | Group 0 | |||||||
| Group 1 | |||||||||
| PP | Group 0 | ||||||||
| Group 1 | |||||||||
| Brain infarct size at 48 +/-24 hours Worst = 1 | ITT | Group 0 | |||||||
| Group 1 | |||||||||
| PP | Group 0 | ||||||||
| Group 1 | |||||||||
| WHODAS 2.0 score at 91+/-14 days | ITT | Group 0 | |||||||
| Group 1 | |||||||||
| PP | Group 0 | ||||||||
| Group 1 | |||||||||
SD standard deviation, NIHSS National Institutes of Health Stroke Score, EQ-5D-5 L EuroQoL quality-of-life scale